Category Specific RSS

Opinion

With their mind blowing medical potential, are hallucinogens the next ASX ‘pot stock’ equivalent?

The mere mention of magic mushrooms, ecstasy or ketamine is enough to send parents of teenagers into conniptions. But are…

5 years ago

The market loves a spin-off

Recently Iluka Resources spun-off their Deterra Royalties business. Deterra earns a royalty on iron ore mining in Mining Area C,…

5 years ago

Is the value trade overbought?

A client asked earlier this week - is the value trade overbought? Our answer was yes but circling back with…

5 years ago

Three ASX listed stocks exposed to single party risk

Last week your columnist delved into the issues facing stocks such as Crown Resorts that rely on the stroke of…

5 years ago

The companies that live or die with the stroke of a regulatory pen

Deep in any corporate vault lies a piece of paper or two that affirms the right of an enterprise to…

5 years ago

3 small cap Artificial Intelligence companies with room to boom

While we may not realise it just yet, many of the services we utilise every day are being powered by…

5 years ago